Contract 36E79722A0025
Telix Pharmaceuticals Us Inc · Department Of Veterans Affairs · July 31, 2024
Telix Pharmaceuticals Us Inc was awarded a federal contract by Department Of Veterans Affairs on July 31, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. This is a task or delivery order issued under parent IDIQ 36F79722D0197. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 29, 2025. If all options are exercised, the contract could reach $17.50 million.
Contract details
- PIID
- 36E79722A0025
- Parent IDIQ
- 36F79722D0197
- Award type
- —
- Pricing
- Firm Fixed Price
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- July 31, 2024
- Latest action
- December 29, 2025
Description
2026 PUBLIC LAW PRICING UPDATES.
Modification timeline
-
December 29, 2025Mod P00009 · Supplemental Agreement For Work Within Scope$0
-
August 1, 2025Mod P00008 · Supplemental Agreement For Work Within ScopeTEMPORARY PRICE REDUCTION - ILLUCCIX$0
-
July 28, 2025Mod P00007 · Exercise An OptionEXERCISE OPTION YEAR 3$0
-
July 31, 2024Mod P00005 · Exercise An OptionEXERCISE OPTION YEAR 2$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36E79722A0025?
Contract 36E79722A0025 is a federal contract awarded to Telix Pharmaceuticals Us Inc by Department Of Veterans Affairs on July 31, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 3 times since the base award.
Who won contract 36E79722A0025?
Telix Pharmaceuticals Us Inc won contract 36E79722A0025 from Department Of Veterans Affairs.
How much is contract 36E79722A0025 worth?
Contract 36E79722A0025 has obligated $0 to date but carries a potential ceiling of $17.50 million if fully funded and all options are exercised.